Global Kidney Cancer Drugs Market Size, Status and Forecast 2019-2025

Published: Jan, 2019 | Pages: 108 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

In 2018, the global Kidney Cancer Drugs market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2019-2025.

This report focuses on the global Kidney Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Cancer Drugs development in United States, Europe and China.

The key players covered in this study
    Pfizer
    Abbott Laboratories
    Glaxosmithkline PLC
    Novartis AG
    Bayer AG
    Active Biotech
    Amgen
    Cipla Limited
    F. Hoffmann-La Roche
    Genentech
    Prometheus Laboratories
    Exelixis
    Onyx Pharmaceuticals
    Aveo Pharmaceuticals
    Immatics Biotechnologies

Market segment by Type, the product can be split into
    Nexavar (Sorafenib)
    Sutent (Sunitinib)
    Afinitor (Everolimus)
    Votrient (Pazopanib)
    Avastin (Bevacizumab)
    Inlyta (Axitinib)
    Torisel (Temsirolimus)
    Proleukin (Aldesleukin)
    Other

Market segment by Application, split into
    Hospitals
    Clinics
    Research Center
    Other

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Kidney Cancer Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Kidney Cancer Drugs development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Kidney Cancer Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Kidney Cancer Drugs Market Size Growth Rate by Type (2014-2025)
        1.4.2 Nexavar (Sorafenib)
        1.4.3 Sutent (Sunitinib)
        1.4.4 Afinitor (Everolimus)
        1.4.5 Votrient (Pazopanib)
        1.4.6 Avastin (Bevacizumab)
        1.4.7 Inlyta (Axitinib)
        1.4.8 Torisel (Temsirolimus)
        1.4.9 Proleukin (Aldesleukin)
        1.4.10 Other
    1.5 Market by Application
        1.5.1 Global Kidney Cancer Drugs Market Share by Application (2014-2025)
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Research Center
        1.5.5 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Kidney Cancer Drugs Market Size
    2.2 Kidney Cancer Drugs Growth Trends by Regions
        2.2.1 Kidney Cancer Drugs Market Size by Regions (2014-2025)
        2.2.2 Kidney Cancer Drugs Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Kidney Cancer Drugs Market Size by Manufacturers
        3.1.1 Global Kidney Cancer Drugs Revenue by Manufacturers (2014-2019)
        3.1.2 Global Kidney Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Kidney Cancer Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Kidney Cancer Drugs Key Players Head office and Area Served
    3.3 Key Players Kidney Cancer Drugs Product/Solution/Service
    3.4 Date of Enter into Kidney Cancer Drugs Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Kidney Cancer Drugs Market Size by Type (2014-2019)
    4.2 Global Kidney Cancer Drugs Market Size by Application (2014-2019)

5 United States
    5.1 United States Kidney Cancer Drugs Market Size (2014-2019)
    5.2 Kidney Cancer Drugs Key Players in United States
    5.3 United States Kidney Cancer Drugs Market Size by Type
    5.4 United States Kidney Cancer Drugs Market Size by Application

6 Europe
    6.1 Europe Kidney Cancer Drugs Market Size (2014-2019)
    6.2 Kidney Cancer Drugs Key Players in Europe
    6.3 Europe Kidney Cancer Drugs Market Size by Type
    6.4 Europe Kidney Cancer Drugs Market Size by Application

7 China
    7.1 China Kidney Cancer Drugs Market Size (2014-2019)
    7.2 Kidney Cancer Drugs Key Players in China
    7.3 China Kidney Cancer Drugs Market Size by Type
    7.4 China Kidney Cancer Drugs Market Size by Application

8 Japan
    8.1 Japan Kidney Cancer Drugs Market Size (2014-2019)
    8.2 Kidney Cancer Drugs Key Players in Japan
    8.3 Japan Kidney Cancer Drugs Market Size by Type
    8.4 Japan Kidney Cancer Drugs Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Kidney Cancer Drugs Market Size (2014-2019)
    9.2 Kidney Cancer Drugs Key Players in Southeast Asia
    9.3 Southeast Asia Kidney Cancer Drugs Market Size by Type
    9.4 Southeast Asia Kidney Cancer Drugs Market Size by Application

10 India
    10.1 India Kidney Cancer Drugs Market Size (2014-2019)
    10.2 Kidney Cancer Drugs Key Players in India
    10.3 India Kidney Cancer Drugs Market Size by Type
    10.4 India Kidney Cancer Drugs Market Size by Application

11 Central & South America
    11.1 Central & South America Kidney Cancer Drugs Market Size (2014-2019)
    11.2 Kidney Cancer Drugs Key Players in Central & South America
    11.3 Central & South America Kidney Cancer Drugs Market Size by Type
    11.4 Central & South America Kidney Cancer Drugs Market Size by Application

12 International Players Profiles
    12.1 Pfizer
        12.1.1 Pfizer Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Kidney Cancer Drugs Introduction
        12.1.4 Pfizer Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.1.5 Pfizer Recent Development
    12.2 Abbott Laboratories
        12.2.1 Abbott Laboratories Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Kidney Cancer Drugs Introduction
        12.2.4 Abbott Laboratories Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.2.5 Abbott Laboratories Recent Development
    12.3 Glaxosmithkline PLC
        12.3.1 Glaxosmithkline PLC Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Kidney Cancer Drugs Introduction
        12.3.4 Glaxosmithkline PLC Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.3.5 Glaxosmithkline PLC Recent Development
    12.4 Novartis AG
        12.4.1 Novartis AG Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Kidney Cancer Drugs Introduction
        12.4.4 Novartis AG Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.4.5 Novartis AG Recent Development
    12.5 Bayer AG
        12.5.1 Bayer AG Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Kidney Cancer Drugs Introduction
        12.5.4 Bayer AG Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.5.5 Bayer AG Recent Development
    12.6 Active Biotech
        12.6.1 Active Biotech Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Kidney Cancer Drugs Introduction
        12.6.4 Active Biotech Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.6.5 Active Biotech Recent Development
    12.7 Amgen
        12.7.1 Amgen Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Kidney Cancer Drugs Introduction
        12.7.4 Amgen Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.7.5 Amgen Recent Development
    12.8 Cipla Limited
        12.8.1 Cipla Limited Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Kidney Cancer Drugs Introduction
        12.8.4 Cipla Limited Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.8.5 Cipla Limited Recent Development
    12.9 F. Hoffmann-La Roche
        12.9.1 F. Hoffmann-La Roche Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Kidney Cancer Drugs Introduction
        12.9.4 F. Hoffmann-La Roche Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.9.5 F. Hoffmann-La Roche Recent Development
    12.10 Genentech
        12.10.1 Genentech Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Kidney Cancer Drugs Introduction
        12.10.4 Genentech Revenue in Kidney Cancer Drugs Business (2014-2019)
        12.10.5 Genentech Recent Development
    12.11 Prometheus Laboratories
    12.12 Exelixis
    12.13 Onyx Pharmaceuticals
    12.14 Aveo Pharmaceuticals
    12.15 Immatics Biotechnologies

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures

    Table Kidney Cancer Drugs Key Market Segments
    Table Key Players Kidney Cancer Drugs Covered
    Table Global Kidney Cancer Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Kidney Cancer Drugs Market Size Market Share by Type 2014-2025
    Figure Nexavar (Sorafenib) Figures
    Table Key Players of Nexavar (Sorafenib)
    Figure Sutent (Sunitinib) Figures
    Table Key Players of Sutent (Sunitinib)
    Figure Afinitor (Everolimus) Figures
    Table Key Players of Afinitor (Everolimus)
    Figure Votrient (Pazopanib) Figures
    Table Key Players of Votrient (Pazopanib)
    Figure Avastin (Bevacizumab) Figures
    Table Key Players of Avastin (Bevacizumab)
    Figure Inlyta (Axitinib) Figures
    Table Key Players of Inlyta (Axitinib)
    Figure Torisel (Temsirolimus) Figures
    Table Key Players of Torisel (Temsirolimus)
    Figure Proleukin (Aldesleukin) Figures
    Table Key Players of Proleukin (Aldesleukin)
    Figure Other Figures
    Table Key Players of Other
    Table Global Kidney Cancer Drugs Market Size Growth by Application 2014-2025 (Million US$)
    Figure Hospitals Case Studies
    Figure Clinics Case Studies
    Figure Research Center Case Studies
    Figure Other Case Studies
    Figure Kidney Cancer Drugs Report Years Considered
    Table Global Kidney Cancer Drugs Market Size 2014-2025 (Million US$)
    Figure Global Kidney Cancer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Kidney Cancer Drugs Market Size by Regions 2014-2025 (Million US$)
    Table Global Kidney Cancer Drugs Market Size by Regions 2014-2019 (Million US$)
    Table Global Kidney Cancer Drugs Market Share by Regions 2014-2019
    Figure Global Kidney Cancer Drugs Market Share by Regions 2014-2019
    Figure Global Kidney Cancer Drugs Market Share by Regions 2019
    Table Market Top Trends
    Table Global Kidney Cancer Drugs Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Kidney Cancer Drugs Market Share by Manufacturers (2014-2019)
    Figure Global Kidney Cancer Drugs Market Share by Manufacturers in 2018
    Table Global Kidney Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Kidney Cancer Drugs Product/Solution/Service
    Table Date of Enter into Kidney Cancer Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table Global Kidney Cancer Drugs Market Size Share by Type (2014-2019)
    Figure Global Kidney Cancer Drugs Market Size Market Share by Type (2014-2019)
    Table Global Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table Global Kidney Cancer Drugs Market Size Share by Application (2014-2019)
    Figure Global Kidney Cancer Drugs Market Size Market Share by Application (2014-2019)
    Figure Global Kidney Cancer Drugs Revenue Market Share by Application in 2018
    Figure United States Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table United States Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table United States Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table United States Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table United States Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table United States Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table United States Kidney Cancer Drugs Market Share by Application (2014-2019)
    Figure Europe Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table Europe Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table Europe Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table Europe Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table Europe Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table Europe Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table Europe Kidney Cancer Drugs Market Share by Application (2014-2019)
    Figure China Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table China Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table China Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table China Kidney Cancer Drugs Market Size by Type (2014-20189) (Million US$)
    Table China Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table China Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table China Kidney Cancer Drugs Market Share by Application (2014-2019)
    Figure Japan Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table Japan Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table Japan Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table Japan Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table Japan Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table Japan Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table Japan Kidney Cancer Drugs Market Share by Application (2014-2019)
    Figure Southeast Asia Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table Southeast Asia Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table Southeast Asia Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Kidney Cancer Drugs Market Share by Application (2014-2019)
    Figure India Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table India Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table India Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table India Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table India Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table India Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table India Kidney Cancer Drugs Market Share by Application (2014-2019)
    Figure Central & South America Kidney Cancer Drugs Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Kidney Cancer Drugs Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Kidney Cancer Drugs Market Share (2018-2019)
    Table Central & South America Kidney Cancer Drugs Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Kidney Cancer Drugs Market Share by Type (2014-2019)
    Table Central & South America Kidney Cancer Drugs Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Kidney Cancer Drugs Market Share by Application (2014-2019)
    Table Pfizer Company Details
    Table Pfizer Revenue in Kidney Cancer Drugs Business (2014-2019) (Million US$)
    Figure Pfizer Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Pfizer Recent Development
    Table Abbott Laboratories Company Details
    Table Abbott Laboratories Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Abbott Laboratories Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Abbott Laboratories Recent Development
    Table Glaxosmithkline PLC Company Details
    Table Glaxosmithkline PLC Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Glaxosmithkline PLC Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Glaxosmithkline PLC Recent Development
    Table Novartis AG Company Details
    Table Novartis AG Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Novartis AG Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Novartis AG Recent Development
    Table Bayer AG Company Details
    Table Bayer AG Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Bayer AG Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Bayer AG Recent Development
    Table Active Biotech Company Details
    Table Active Biotech Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Active Biotech Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Active Biotech Recent Development
    Table Amgen Company Details
    Table Amgen Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Amgen Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Amgen Recent Development
    Table Cipla Limited Company Details
    Table Cipla Limited Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Cipla Limited Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Cipla Limited Recent Development
    Table F. Hoffmann-La Roche Company Details
    Table F. Hoffmann-La Roche Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure F. Hoffmann-La Roche Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table F. Hoffmann-La Roche Recent Development
    Table Genentech Company Details
    Table Genentech Revenue in Kidney Cancer Drugs Business (2014-2019)(Million US$)
    Figure Genentech Revenue Growth Rate in Kidney Cancer Drugs Business (2014-2019)
    Table Genentech Recent Development
    Table Prometheus Laboratories Company Details
    Table Exelixis Company Details
    Table Onyx Pharmaceuticals Company Details
    Table Aveo Pharmaceuticals Company Details
    Table Immatics Biotechnologies Company Details
    Table Global Kidney Cancer Drugs Market Size by Regions (Million US$) 2019-2025
    Figure Global Kidney Cancer Drugs Market Size Share by Regions (2019-2025)
    Figure Global Kidney Cancer Drugs Market Size Share by Regions in 2025
    Figure United States Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure China Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure India Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Kidney Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
    Table Global Kidney Cancer Drugs Market Size by Product (2019-2025) (Million US$)
    Figure Global Kidney Cancer Drugs Market Size by Product (2019-2025)
    Figure Global Kidney Cancer Drugs Market Size by Product in 2025
    Table Global Kidney Cancer Drugs Market Size by Application (2019-2025) (Million US$)
    Figure Global Kidney Cancer Drugs Market Size by Application (2019-2025)
    Figure Global Kidney Cancer Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources